Exome Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
Exome Asset Management's NBP Position: Q3 2026 in Review
Exome Asset Management held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q3 2026 at 576,960 shares worth $788K. The position accounts for 0.51% of the portfolio, ranked #48.
Exome Asset Management first reported a position in NBP in Q1 2024 and has held it in 7 quarters since. The position peaked at $5.44M in Q3 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q3 2026.
- Exome Asset Management held 576,960 shares of NovaBridge Biosciences American Depositary Shares worth $788K as of Q3 2026.
- Exome Asset Management left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q3 2026.
- NovaBridge Biosciences American Depositary Shares made up 0.51% of Exome Asset Management's portfolio in Q3 2026, its #48 holding.
- Exome Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2024 and has held it in 7 quarters since.
- Exome Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $5.44M in Q3 2025.
- 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.
Based on Exome Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.